Sarepta Therapeutics Inc (SRPT)

123.46 -3.67 (-2.89%)
Closed USD Disclaimer
123.45 -0.01 (-0.01%)

SRPT Financial Summary

Sarepta Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 413.46 million compared to USD 253.5 million a year ago. Net income was USD 36.12 million compared to net loss of USD 516.76 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to basic loss per share from continuing operations of USD 5.86 a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to diluted loss per share from continuing operations of USD 5.86 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
SRPT
Gross margin TTM 28.88%
Operating margin TTM -6.76%
Net Profit margin TTM 1.2%
Return on Investment TTM -3.73%
Total Revenue
Net Income
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Revenue 413.46 396.78 331.82 261.24
Gross Profit 162.51 157.09 100.49 -14.78
Operating Income 34.90 24.62 -20.84 -133.52
Net Income 36.12 45.66 -40.94 -23.94
Clear All
0Selected
Please try another search
SRPT
Quick Ratio MRQ 2.96
Current Ratio MRQ 4.05
LT Debt to Equity MRQ 117.94%
Total Debt to Equity MRQ 145.2%
Total Assets
Total Liabilities
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Assets 3,224.38 3,264.58 3,109.71 3,125.89
Total Liabilities 2,263.19 2,405.24 2,345.35 2,384.48
Total Equity 961.19 859.34 764.36 741.41
Clear All
0Selected
Please try another search
SRPT
Cash Flow/Share TTM -5.69
Revenue/Share TTM 14.95
Operating Cash Flow -39.77%
Cash
Net Change in Cash
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Cash From Operating Activities -242.08 -54.66 -114.71 -122.23
Cash From Investing Activities 218.80 -64.36 -210.57 96.63
Cash From Financing Activities 22.14 1.94 15.40 5.86
Net Change in Cash -1.14 -117.07 -309.87 -19.74
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.